A CASE OF IMMUNE CHECKPOINT INHIBITOR ASSOCIATED MYOCARDITIS IN NON-SMALL CELL LUNG CANCER

被引：0
|
作者：
Murphy, Andrew [1 ]
Ismail, Ali [1 ]
Monzer, Nasser [1 ]
Sangoi, Matthew [1 ]
Khan, Aarish Husain [1 ]
Khazan, Benjamin [1 ]
机构：
[1] Univ Penn Hlth Syst, Penn Hosp, Philadelphia, PA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1260-038
引用
收藏
页码：3191 / 3191
页数：1
相关论文
共 50 条
  • [31] Immune checkpoint inhibitors in advanced non-small cell lung cancer
    Fabre, Elizabeth
    Pecuchet, Nicola
    Cadranel, Jacques
    BULLETIN DU CANCER, 2016, 103 : S138 - S143
  • [32] Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer
    Assi, Hazem I.
    Kamphorst, Alice O.
    Moukalled, Nour M.
    Ramalingam, Suresh S.
    CANCER, 2018, 124 (02) : 248 - 261
  • [33] Reflections on immune checkpoint inhibition in non-small cell lung cancer
    Leventakos, Konstantinos
    Mansfield, Aaron S.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2014, 3 (06) : 411 - 413
  • [34] Pneumonitis associated with immune checkpoint inhibitors among patients with non-small cell lung cancer
    Shannon, Vickie R.
    CURRENT OPINION IN PULMONARY MEDICINE, 2020, 26 (04) : 326 - 340
  • [35] Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer
    Mezquita, Laura
    Auclin, Edouard
    Ferrara, Roberto
    Charrier, Melinda
    Remon, Jordi
    Planchard, David
    Ponce, Santiago
    Paz Ares, Luis
    Leroy, Laura
    Audigier-Valette, Clarisse
    Felip, Enriqueta
    Zeron-Medina, Jorge
    Garrido, Pilar
    Brosseau, Solenn
    Zalcman, Gerard
    Mazieres, Julien
    Caramela, Caroline
    Lahmar, Jihene
    Adam, Julien
    Chaput, Nathalie
    Soria, Jean Charles
    Besse, Benjamin
    JAMA ONCOLOGY, 2018, 4 (03) : 351 - 357
  • [36] The mechanism and risk factors for immune checkpoint inhibitor pneumonitis in non-small cell lung cancer patients
    Xiaoyang Zhai
    Jian Zhang
    Yaru Tian
    Ji Li
    Wang Jing
    Hongbo Guo
    Hui Zhu
    Cancer Biology & Medicine, 2020, 17 (03) : 599 - 611
  • [37] Efficacy of Immune Checkpoint Inhibitor on Non-Small Cell Lung Cancer with Chronic Obstructive Pulmonary Disease
    Zhang, Huohuo
    Li, Weimin
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [38] Vimentin expression correlates with immune-checkpoint inhibitor efficacy in non-small cell lung cancer
    Nakahama, Kenji
    Izumi, Motohiro
    Yoshimoto, Naoki
    Fukui, Mitsuru
    Sugimoto, Akira
    Nagamine, Hiroaki
    Ogawa, Koichi
    Sawa, Kenji
    Tani, Yoko
    Kaneda, Hiroyasu
    Mitsuoka, Shigeki
    Watanabe, Tetsuya
    Asai, Kazuhisa
    Kawaguchi, Tomoya
    CANCER, 2023, 129 (15) : 2297 - 2307
  • [39] Obesity paradox in patients with non-small cell lung cancer undergoing immune checkpoint inhibitor therapy
    Lee, Ji Hyun
    Kang, Danbee
    Ahn, Jin Seok
    Guallar, Eliseo
    Cho, Juhee
    Lee, Ho Yun
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2023, 14 (06) : 2898 - 2907
  • [40] Efficacy and safety of immune checkpoint inhibitor monotherapy in elderly patients with non-small cell lung cancer
    Chikaishi, Yasuhiro
    Inoue, Masaaki
    Kusanagi, Kasumi
    Honda, Yohei
    Yoshida, Junichi
    Tanaka, Masao
    AGING MEDICINE, 2021, 4 (01) : 42 - 46
12345